Delivery Order SPE2DB24D1205-SPE2DB25FCTDK
Award Date
1/17/25
Potential Completion Date
1/21/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The fixed-price delivery order, valued at $4,728.70, has an ultimate completion date of August 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,692.87 Firm Fixed Price Delivery Order contract is for the supply of 4566976401 RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has a completion date of January 21, 2025 and was awarded on January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $13,847.91, issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO is for the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML, with a period of performance ending on December 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this contract, which does not have a set-aside designation. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,892.20 firm fixed-price delivery order covers the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 11, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,997.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a completion date of May 17, 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVHPK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $6,161.50 firm-fixed-price delivery order is for the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of May 16, 2024.
Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, holds a...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $4,657.38 for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 17, 2025.
The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,892.20 firm fixed-price delivery order is for the supply of 4,566,692,708 units of the medication RUXIENCE 500 MG/50 ML VIAL 50ML. This contract does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $6,359.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RUXIENCE 500 mg/50 ml vials and has an ultimate completion date of January 16, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,484.87 firm-fixed-price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a medication used to treat certain medical conditions.
Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company...